Early Access — free while we kick the tires
EdgarHawk

Mandadi Tilak

EVP, Chief Exp & Tech Officer

Officer

Latest: EVP, Chief Exp & Tech Officer selling · May 2026

1 filing analyzed · 1 company · Latest 2026-05-11

Companies

Company Buys Sells Direction
CVS HEALTH Corp CVS 0 1 Net selling

Activity

May 2026
2026-05-11 CVS HEALTH Corp CVS
medium
Sell
69,551 shares
$6,230,379
Significance 4/10

CVS Chief Exp & Tech Officer Mandadi Tilak sells 87% of holdings in single transaction.

Mandadi Tilak, CVS's Chief Experience and Technology Officer, executed a substantial sale disposing of the majority of his holdings. This is his first open-market sale in the three-year period; his prior Form 4 activity consisted entirely of stock-based compensation transactions. The sale occurred as the stock trades at its 52-week high, having rallied significantly over the past three months. CVS remains a profitable company with growing revenue, though it trades at a relatively elevated valuation multiple. The timing of this large exit—coming from an executive with direct operational responsibility while the stock has recently strengthened—warrants attention as a potential signal of insider reassessment, though the singular nature of this trade and the absence of broader insider selling prevents a high-confidence interpretation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access